16th Annual Canadian Endocrine Update Scientific Meeting CEU

Schedule

Start 9 April, 2021, 8 25 AM

End 4 PM

Location

No street address specified

No city specified

No Province / Territory specified

No country specified

Contact Info

Cheryl Bogie, CHSE Coordinator

Phone: 905-525-9140 ext. 22990

E-Mail: bogie@mcmaster.ca

No website provided


Download the presentations

Day 1 - Live Recordings

Day 2 - Live Recordings

*You will require the password emailed to you



Download the brochure

Download the Endocrine CEU 2021 Friday agenda


Sign-up for email updates

REGISTRATION IS NOW CLOSED


 

Evaluations Day 1

 

Overall Program Evaluation Day 1

Hertzel Gerstein
Effect of Novel Glucose–Lowering Therapies on Clinically Important Outcomes in T2DM 
Evaluate Hertzel Gerstein

Andre Lacroix
Adrenal Insufficiency – Diagnosis and Management 
Evaluate Andre Lacroix

Denis Feig
Technologies in the management of type 1  diabetes during pregnancy 
Evaluate Denice Feig

Stan Van Uum
Testosterone Replacement: who, when and how
Evaluate Stan Van Uum

Aliya Khan
X-linked Hypophosphatemia (XLH) – how to diagnose and intervene 
Evaluate Aliya Khan

Ally Prebtani
Adrenal Incidentaloma – challenging cases - 
Evaluate  Ally Prebtani

Tayyab Khan
SESSION A: Challenging cases in osteoporosis therapy 
Evaluate Tayyab Khan

Deric Morrison
SESSION B: Graves disease – Diagnosis and Management 
Evaluate  Deric Morrison

Christine Derzko
HRT for women 
Evaluate Christine Derzko

Terry Paul
Anabolic Therapies for Postmenopausal Osteoporosis
Evaluate Terri Paul

Robert Hegele
Dyslipidemia – challenge cases - 
Evaluate Robert Hegel




Friday, April 9, 2021

 

The CEU Meeting presents advances in Endocrinology & Metabolism with state of the art lectures by leading national and international faculty.



TARGET AUDIENCE

Endocrinologists, Internal Medicine, Paediatrics, MD, Diabetes Educators, Nurse Practitioner and Trainees in Endocrinology. 

LEARNING OBJECTIVES

By attending this activity, through a variety of interactive and informative sessions, participants will be able to:

  • Comprehend and implement advances in the diagnosis and management of lipid and calcium disorders, diabetes, genetic aspects of endocrine diseases, osteoporosis and hypogonadism.
  • Acquire and fine-tune approach to managing outpatient and inpatient endocrine problems. 

 

ACCREDITATION STATEMENT

McMaster University, Continuing Health Sciences Education Program (CHSE) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide CFPC Mainpro+ and RCPSC Maintenance of Certification (MOC) study credits for Continuing Medical Education.

This Group Learning program meets the certification criteria of The College of Family Physicians of Canada and has been certified by McMaster University Continuing Health Sciences Education Program for up to 6.25 Mainpro+ credits.

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by McMaster University Continuing Health Sciences Education Program for up to 6.25 MOC Section 1 credits.

The American Medical Association: Through an agreement between The Royal College of Physicians and Surgeons of Canada and The American Medical Association, Physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at: www.ama-assn.org/go/internationalcme

*Each healthcare provider should claim only those hours of credit that he/she actually spent in the educational activity.




Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsweb@mcmaster.ca.